Position in NUVL
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$917,132
+$53,668 QoQ
Shares Held
8,952
+4.3% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in NUVL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026EVERGREEN CAPITAL MANAGEMENT LLC holds $21,167,675 across 26 Biotechnology names. NUVL ranks #4 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
13,090 | $10,113,857 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,107 | $2,280,479 | |
| 3 | RPRX |
Royalty Pharma plc
|
19,335 | $927,499 | |
| 4 | NUVL |
Nuvalent, Inc.
This page
|
8,952 | $917,132 | |
| 5 | PBYI |
Puma Biotechnology, Inc.
|
96,000 | $613,440 | |
| 6 | GMAB |
Genmab A/S
|
20,779 | $557,500 | |
| 7 | ARGX |
Argenx SE
|
690 | $503,872 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
2,591 | $489,827 |
All Filings in NUVL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $917,132 | 8,952 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $863,464 | 8,584 | Shares | Other | 2026-01-27 | |
| No filing history on record for this holder in this stock. | ||||||